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Objective: to evaluate the efficacy of percutaneous transluminal angioplasty (PTA) of the crural arteries.
Patients and methods: a retrospective review of patients treated with PTA of at least one crural artery during an 8-
year period (1990–1997).
Results: one hundred and fifty-five legs in 140 consecutive patients (mean age 74 years, range 38–91 years) were treated.
In 76% a more proximal lesion was also treated. After 1 year, results were significantly better in non-diabetics
(improvement rate of 66% vs 32%; p<0.05). The outcome for patients with a combination of diabetes, heart disease and
renal disease was significantly worse compared to all other patients with an improvement rate of only 9% after 1 year.
Patients alive and not amputated at 1 year were significantly more common (p<0.05) among non-diabetics (90%),
compared to diabetics (66%). The 1-year mortality for the whole group was 15%, significantly higher for diabetic patients
(p=0.04).
Conclusion: PTA of crural arteries produces reasonably good results in non-diabetic patients. Diabetic patients were
doing worse than non-diabetics after a year, though 1-month results were not significantly different. Patients with
diabetes, heart disease and renal disease make a high-risk group that has a significantly worse outcome.
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Introduction of different risk factors on outcome has not been
properly defined, although most studies have shown
Surgical treatment with bypass procedures in patients that diabetic patients do worse,7. Other reports have
not shown any significant adverse effects of associatedsuffering critical limb ischemia (CLI) caused by crural
artery stenoses and occlusions has been the standard diseases.4 As the use of PTA on crural arteries has
increased steadily,8 it is important to evaluate the effectfor the last 10–15 years. The percutaneous transluminal
angioplasty (PTA) technique utilising fine calibre cath- of this treatment and find some guidelines for proper
patient selection. Therefore in this retrospective studyeters and hydrophilic steerable wires makes it possible
to treat lesions in crural arteries, but the exact role of we have re-evaluated our results during an 8-year
period, looking specifically at the outcome for diabeticthis treatment is still to be defined. In recent years
reports have shown favourable results with a primary patients.
patency of 36–68% after 1 year and low morbidity and
mortality.1 Even more favourable results have been
reported with the use of subintimal angio-
plasty.2,3 The rate of technical failures has varied be-
tween 0% and 12%.4,5 Other reports have shown mark- Patients and Methods
edly worse results of infrainguinal PTA with 1-year
patency rates of less than 15%.6 However, because of All patients treated with PTA of at least one crural
the great variation in patient selection and in defining artery, between January 1990 and December 1997, were
outcome, it is difficult to compare results. The effect included in this retrospective study. Records for 140
patients were analysed regarding demographics,
symptoms, signs, past medical history and ankle bra-∗ Please address all correspondence to: G. Danielsson, Department
of Surgery, Lund University Hospital, S-22185, Lund, Sweden. chial pressure index (ABPI). Fifteen patients were
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Table 1. Patients’ characteristics. Table 3. Clinical outcome of patients (155 legs) with and without
diabetes.
Diabetics Non- Total
diabetics Diabetes Non-diabetes
(n=85) (n=70)(n=80) (n=60) (n=140)
(legs=85) (legs=70) (legs=155)
Improved:
One month 47 (55%) 48 (68%) n.s.Mean age (range) 72 (38–90) 77 (41–91) 74 (38–91)
Male/Female 54/26 28/32 82/58 One year 27 (32%) 46 (66%) p<0.001
Amputation 13 (15%) 1 (1.5%) p<0.01Heart disease 61 (72%) 42 (60%) 103 (66%) n.s.
Hypertension 36 (42%) 20 (29%) 56 (36%) n.s. One year mortality 18/80 (23%) 6/60 (10%) n.s.
Alive without 66% 90% p=0.05Renal disease 28 (33%) 10 (14%) 38 (25%) (p<0.01)
Cerebrovascular 16 (19%) 20 (29%) 36 (23%) n.s. amputation
disease
Table 2. Indication for treatment (155 legs). of stenoses and the number and length of occlusions
was recorded. Stenoses were classified into three cat-Diabetics Non- Total
egories, 50–75%, 75–90% and >90%. Occlusions werediabetics
(n=85) (n=70) measured in mm. The angiograms were evaluated
concerning success of the treatment as optimal if sten-Ulcer/gangrene 65 (76%) 32 (46%) 97 (63%) p<0.001
osis/occlusion was reduced to less than 30% residualRest pain 16 (19%) 26 (37%) 42 (27%)
Intermittent 4 (5%) 12 (17%) 16 (10%) stenosis, suboptimal if residual stenosis was between
claudication 30–50% and failure if continuity to the foot arteries
was not restored. At 1 month and 1 year the clinical
outcome was analysed in terms of death, amputation,
treated in both legs. Demographics appear in Table 1. unsuccessful outcome (retained leg, but no im-
Eighty patients (56%) had diabetes. provement) or successful outcome (improvement). Im-
The indication for treatment was ulcer or gangrene provement was defined subjectively as relief of rest
in 63%, rest pain in 27% and intermittent claudication pain, partial or total healing of ulcers or increased
in 10% (Table 2). Nineteen patients (14%) were cur- walking distance. Duplex ultrasonography or angio-
rently smoking, 14 (10%) were ex-smokers. Sixty graphy was not performed at follow-up and con-
patients (44%) claimed that they had never smoked. sequently patency cannot be described.
No information on smoking habits was available in
45 cases (32%).
Out of 155 treated legs, 118 (76%) were also treated
for a more proximal lesion (superficial femoral or Statistics
popliteal artery), while in 37 cases (24%) only crural
arteries were treated (tibioperoneal trunk, anterior Results were analysed by Mann–Whitney t-test for
tibial, posterior tibial or peroneal artery). In more than non-parametric data. Patients with and without dia-
half of the treatments (78/155) more than one crural betes were compared with respect to time to am-
artery was treated. The treated lesion was localised to putation and survival time. The exact log rank test
the tibioperoneal trunk in 109 cases, the anterior tibial was employed (StatXact 3, Cytel Software Corp., Cam-
artery in 51 cases, the posterior tibial artery in 25 cases bridge, MA, U.S.A.). Patients who died within one
and the peroneal artery in 55 cases. year after operation were treated as censored at their
Occlusions and stenoses of the superficial femoral time of death in the analysis of time to amputation. A
or popliteal artery were dilated with a 6 mm PTA- p-value <0.05 was considered significant.
balloon. The occlusions were normally passed in-
traluminally but in a few cases a subintimal technique
was used. Occlusions and stenoses in the crural arteries
were passed with a 0.014″ guidewire, normally one Results
vessel at a time. Cordis Europass or Worldpass bal-
loons, 30 mm in length, with a diameter of 4.0 mm in Clinical outcome
the upper part down to 2.0 mm in the distal part of
the crural vessels were used (Cordis Corp., Miami, FL, One patient died during the first month, while the 1-
year mortality for the whole group was 15% (23%U.S.A.). At the re-evaluation, a vascular surgeon and
an interventional radiologist reviewed the angiograms. and 10% for diabetics and non-diabetics, respectively)
(Table 3). Log-rank test showed a significant differenceThe number of treated arteries as well as the number
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Table 4. Number of treated crural arteries in diabetic patients.
1 artery >1 artery
Number (legs) 43 42
Improved:
One month 26 (60%) 21 (50%) n.s.
One year 15 (35%) 12 (29%) n.s.
patients were improved (66% vs 32%, p<0.005) (Table
3).
There was no difference in clinical outcome for
patients treated for crural lesions only or for combined
lesions, neither at 1 month, nor at 1 year.
Fig. 1. Kaplan–Meier curves describing survival proportions for
operated patients with diabetes (n=80, solid curve) and without
diabetes (n=60, dotted curve), respectively.
Technical outcome
Two patients had to be operated on because of im-
mediate problems after PTA. One patient had bleeding
in the groin and another had a femoro-distal bypass,
due to aggravation of the leg ischaemia. One patient
had a thrombotic occlusion of the treated crural artery
a few hours after treatment, which was cleared with
thrombolysis. Thus three patients had major com-
plications (2%), otherwise no PTA complications re-
quiring intervention were seen. Five patients
developed haematoma in the groin (3%). None of them
needed transfusion.
An optimal technical result of PTA was recorded in
144 cases (93%). Ten PTA were classified as suboptimal,Fig. 2. Kaplan–Meier curves describing amputation proportions for
operated legs of patients with diabetes (n=85, solid curve) and but this fact did not influence the clinical outcome.
without diabetes (n=70, dotted curve), respectively. One unsuccessful PTA was recorded. The average
number of treated arteries (including superficial fem-
oral and popliteal arteries) was 2.5 (range 1–5).(p=0.04, Fig. 1). Amputation above the ankle had to
be performed in 13 diabetics and one non-diabetic The number of treated crural arteries (1 compared
to >1) did not affect the 1 month or the 1 year technical(15% vs 1.5%) (log-rank test, Fig. 2, p=0.002). Toe or
forefoot amputation was done in 8 diabetics and 1 result. Out of 43 diabetic patients with treatment of
one crural artery only, 60% reported improvement atnon-diabetic patient. After a year 66% of diabetic
and 90% of non-diabetic patients (p<0.05) were alive 1 month and 35% at 1 year. Corresponding figures for
42 diabetic patients with treatment of more than onewithout a major amputation. During the first year 23
patients, of whom 70% were diabetics, had a redo crural artery were 50% and 29% respectively (Table
4).procedure, 14 had a secondary PTA while nine had
an infrainguinal bypass procedure. These patients are The combination of diabetes, heart disease and renal
disease (22 patients) significantly influenced the out-in the following counted as failures.
After 1 month 95 patients reported improvement, come of PTA, as in this group at 1 month only seven
(32%) reported improvement and at 1 year eight had47 diabetics (55%) and 48 non-diabetics (68%). After
1 year significantly more non-diabetic than diabetic died, nine reported impairment, three were unchanged
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Table 5. Outcome in patients with diabetes, cardiac and renal Royal Infirmary10, similar results were found regarding
disease.
patency. Slightly more than half of their patients had
Diabetes, Others diabetes and the mean age was 72 years. With a mean
cardiac and follow-up period of 18 months the primary patency
renal disease
rate was 38%. Similar results were reported by Lofberg
Number of legs 22 133 et al.11 and Criado et al.12 These series reported diabetics
Improved: and non-diabetics together and no comparison be-One month 7 (32%) 78 (59%) p<0.05
tween the groups was made.One year 2 (9%) 71 (54%) p<0.001
Amputated 2 9 Focusing on diabetic patients, there may be various
Dead 8 (3 14 explanations for their worse outcome. Diabetics hadamputated)
significantly more renal disease (33% vs 14%, p=0.007)
and numerically also more cardiac disease (72% vs
and only two were still improved (Table 5). Of the 60%, p=0.124), representing more severe athero-
10 patients with insulin dependent diabetes, heart sclerotic disease. They also had a more advanced
disease, hypertension and renal disease, none was peripheral vascular disorder, as the number of patients
improved after 1 year. with ischaemic lesions was significantly larger in this
group (76% vs 46%, p<0.005). On the other hand, the
outcome was not worse for patients with lesions than
for those without. The fact that diabetic patients were
Discussion younger than non-diabetics may be explained by the
common finding that diabetes causes early arterial
The present series presents the clinical outcome after disease.
crural angioplasty in diabetic and non-diabetic There was great variation between the frequency of
patients. Reported improvement is based on subjective treatment of the different crural arteries, thus in 109
views, as patency was not investigated. Neither was it cases the tibioperoneal trunk was treated, in 55 the
possible to get ABPI data on all patients. Complications peroneal artery and in 51 the anterior tibial artery.were rare, and the results were quite similar for those
Only in 25 cases was angioplasty performed of thepatients treated with single and multiple PTA of crural
posterior tibial artery. This is in line with other authorsarteries. Furthermore, the combination of femoral and
like Horvath et al.,13 Wack et al.14 and Flueckiger et al.15crural artery angioplasty does not influence the results
In summary, our experience is that for non-diabeticcompared to treatment of crural lesions alone.
patients with crural artery lesions, angioplasty is use-The 1-year results for non-diabetic patients are ac-
ful, provided an appropriate vascular morphologyceptable, while those results achieved for diabetic
exists. The selection between a distal bypass procedurepatients are more questionable. It is, however, worth
and PTA depends merely on vascular morphologyconsidering that patients suffering CLI who constitute
and the patient’s general condition. In each case anthe majority of cases have a bad prognosis for survival,
individualisation of the treatment is required. Fora 1-year mortality rate of 20% is frequently reported.9
diabetic patients one might conclude that a moreSevere CLI symptoms, ulcers and gangrene as well as
restrictive policy concerning PTA should be justified,rest pain may justify even only a short-term benefit
especially for those with concomitant cardiac and renalfrom a treatment procedure. The present 1-month
disease. On the other hand, if relief of symptoms canoutcome with 55% improvement in diabetic patients
be achieved even on a short-term basis, an activemight be acceptable, although it is reduced to 32% at
attitude is reasonable. Again, individualisation is thea year. Diabetic patients had in this series the expected
key to the most appropriate selection of treatment for1-year mortality rate of around 20%, while non-dia-
all severely diseased patients.betics had a better outcome with a 1-year mortality
There is no indication to treat patients with in-rate of only 10%. This figure may reflect a positive
termittent claudication with PTA of single cruralselection of patients and, furthermore, an important
lesions, but sometimes patients undergoing a femoralfact is that 17% of them had intermittent claudication
angioplasty have a restricted run off, and crural arteriesonly. The improvement rate after 1 year was sig-
are therefore treated. There is little evidence whethernificantly better for non-diabetics even if patients with
this is necessary, but in the 16 cases we had acceptedintermittent claudication were excluded from the com-
in this series no complications were seen, and on aparison (64% vs 33%, p<0.005).
very selective basis we do find this additional measureIn a retrospective study of 39 patients who were
treated with PTA of crural arteries from Derbyshire justified.
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